Birth Control Pills Market by Product Type, Hormone, End User - Global Industry Analysis & Forecast to 2027
Published On : October 2019 Pages : 160 Category: Pharmaceuticals Report Code : HC106455
Birth Control Pills Market By Product (Oral Contraceptive Pills, Injectable Birth Control, Emergency Contraceptive Pills, Vaginal Rings, and Transdermal Patches), Hormone (Progestin-only Contraceptive and Combined Hormonal Contraceptive) End User (Hospitals, Household, and Clinics)- Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The Birth Control Pills Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Hormonal contraceptives are conception prevention techniques, which follow up on the endocrine framework. These techniques incorporate the utilization of hormones that are created regularly by ladies, for example, estrogen and progesterone, to avoid ovulation and thus pregnancy. Notwithstanding, they don't give assurance against HIV or other explicitly transmitted diseases. Two kinds of hormonal contraceptives are accessible in the market progestin-just preventative and blend hormonal prophylactic.
Drivers and Restraints
The significant driving components of the market development are an increment in the center towards family arranging and a requirement for avoiding unintended pregnancy. The progression in hormonal contraception with upgraded viability and fewer symptoms are relied upon to further lift the market development. Additionally, medical problems related to high school pregnancies, increment in mindfulness towards present-day contraception techniques and ascend being used of oral pills as a key strategy to forestall spontaneous pregnancy fuel the market development. Nonetheless, accessibility of substitute preventative techniques, wellbeing dangers related to the utilization of contraceptives, and absence of social acknowledgment unfavorably influence the market development.
Regional Insights
The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Bayer Healthcare
- Amgen Inc.
- Baxter
- Gilead Sciences Inc.
- GlaxoSmithKline PLC
- Johnson & Johnson
- Merck & Co. Inc.
- Novartis AG
- Pfizer Inc.
- Sanofi
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Birth Control Pills Market, By Type, Estimates and Forecast, 2017-2027 ($Million)
o Oral Contraceptive Pills
o Injectable Birth Control
o Emergency Contraceptive Pills
o Vaginal Rings
o Transdermal Patches
· Birth Control Pills Market, By Hormone, Estimates and Forecast, 2017-2027 ($Million)
o Progestin-only Contraceptive
o Combined Hormonal Contraceptive
· Birth Control Pills Market, By End User, Estimates and Forecast, 2017-2027 ($Million)
o Hospitals
o Household
o Clinics
· Birth Control Pills Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o Bayer Healthcare
o Amgen Inc.
o Baxter
o Gilead Sciences Inc.
o GlaxoSmithKline PLC
o Johnson & Johnson
o Merck & Co. Inc.
o Novartis AG
o Pfizer Inc.
o Sanofi
· Birth Control Pills Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Submarine Cables Market, By Country
o U.S. Submarine Cables Market
o Canada Submarine Cables Market
o Mexico Submarine Cables Market
o Europe
§ Europe Submarine Cables Market, By Country
o Germany Submarine Cables Market
o UK Submarine Cables Market
o France Submarine Cables Market
o Russia Submarine Cables Market
o Italy Submarine Cables Market
o Rest of Europe Submarine Cables Market
o Asia-Pacific
§ Asia-Pacific Submarine Cables Market, By Country
o China Submarine Cables Market
o Japan Submarine Cables Market
o South Korea Submarine Cables Market
o India Submarine Cables Market
o Southeast Asia Submarine Cables Market
o Rest of Asia-Pacific Submarine Cables Market
o South America
§ South America Submarine Cables Market
o Brazil Submarine Cables Market
o Argentina Submarine Cables Market
o Columbia Submarine Cables Market
o Rest of South America Submarine Cables Market
o Middle East and Africa
§ Middle East and Africa Submarine Cables Market
o Saudi Arabia Submarine Cables Market
o UAE Submarine Cables Market
o Egypt Submarine Cables Market
o Nigeria Submarine Cables Market
o South Africa Submarine Cables Market
o Rest of MEA Submarine Cables Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Birth Control Pills Market, By Type
5.1. Introduction
5.2. Global Birth Control Pills Revenue and Market Share by Type (2017-2027)
5.2.1. Global Birth Control Pills Revenue and Revenue Share by Type (2017-2027)
5.3. Oral Contraceptive Pills
5.3.1. Global Oral Contraceptive Pills Revenue and Growth Rate (2017-2027)
5.4. Injectable Birth Control
5.4.1. Global Injectable Birth Control Revenue and Growth Rate (2017-2027)
5.5. Emergency Contraceptive Pills
5.5.1. Global Emergency Contraceptive Pills Revenue and Growth Rate (2017-2027)
5.6. Vaginal Rings
5.6.1. Global Vaginal Rings Revenue and Growth Rate (2017-2027)
5.7. Transdermal Patches
5.7.1. Global Transdermal Patches Revenue and Growth Rate (2017-2027)
6. Birth Control Pills Market, By Hormones
6.1. Introduction
6.2. Global Birth Control Pills Revenue and Market Share by Hormones (2017-2027)
6.2.1. Global Birth Control Pills Revenue and Revenue Share by Hormones (2017-2027)
6.3. Progestin-only Contraceptive
6.3.1. Global Progestin-only Contraceptive Revenue and Growth Rate (2017-2027)
6.4. Combined Hormonal Contraceptive
6.4.1. Global Combined Hormonal Contraceptive Revenue and Growth Rate (2017-2027)
7. Birth Control Pills Market, By End User
7.1. Introduction
7.2. Global Birth Control Pills Revenue and Market Share by End User (2017-2027)
7.2.1. Global Birth Control Pills Revenue and Revenue Share by End User (2017-2027)
7.3. Hospitals
7.3.1. Global Hospitals Revenue and Growth Rate (2017-2027)
7.4. Household
7.4.1. Global Household Revenue and Growth Rate (2017-2027)
7.5. Clinics
7.5.1. Global Clinics Revenue and Growth Rate (2017-2027)
8. Birth Control Pills Market, By Region
8.1. Introduction
8.2. Global Birth Control Pills Revenue and Market Share by Regions
8.2.1. Global Birth Control Pills Revenue by Regions (2017-2027)
8.3. North America Birth Control Pills by Countries
8.3.1. North America Birth Control Pills Revenue and Growth Rate (2017-2027)
8.3.2. North America Birth Control Pills Revenue (Million USD) by Countries (2017-2027)
8.3.3. United States
8.3.3.1. United States Birth Control Pills Revenue (Millions USD) and Growth Rate (2017-2027)
8.3.4. Canada
8.3.4.1. Canada Birth Control Pills Revenue (Millions USD) and Growth Rate (2017-2027)
8.3.5. Mexico
8.3.5.1. Mexico Birth Control Pills Revenue (Millions USD) and Growth Rate (2017-2027)
8.4. Europe Birth Control Pills by Countries
8.4.1. Europe Birth Control Pills Revenue and Growth Rate (2017-2027)
8.4.2. Europe Birth Control Pills Revenue (Million USD) by Countries (2017-2027)
8.4.3. Germany
8.4.3.1. Germany Birth Control Pills Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.4. France
8.4.4.1. France Birth Control Pills Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.5. UK
8.4.5.1. UK Birth Control Pills Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.6. Russia
8.4.6.1. Russia Birth Control Pills Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.7. Italy
8.4.7.1. Italy Birth Control Pills Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.8. Rest of Europe
8.4.8.1. Rest of Europe Birth Control Pills Revenue (Millions USD) and Growth Rate (2017-2027)
8.5. Asia-Pacific Birth Control Pills by Countries
8.5.1. Asia-Pacific Birth Control Pills Revenue and Growth Rate (2017-2027)
8.5.2. Asia-Pacific Birth Control Pills Revenue (Million USD) by Countries (2017-2027)
8.5.3. China
8.5.3.1. China Birth Control Pills Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.4. Japan
8.5.4.1. Japan Birth Control Pills Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.5. Korea
8.5.5.1. Korea Birth Control Pills Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.6. India
8.5.6.1. India Birth Control Pills Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.7. Southeast Asia
8.5.7.1. Southeast Asia Birth Control Pills Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.8. Rest of Asia-Pacific
8.5.8.1. Rest of Asia-Pacific Birth Control Pills Revenue (Millions USD) and Growth Rate (2017-2027)
8.6. South America Birth Control Pills by Countries
8.6.1. South America Birth Control Pills Revenue and Growth Rate (2017-2027)
8.6.2. South America Birth Control Pills Revenue (Million USD) by Countries (2017-2027)
8.6.3. Brazil
8.6.3.1. Brazil Birth Control Pills Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.4. Argentina
8.6.4.1. Argentina Birth Control Pills Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.5. Columbia
8.6.5.1. Columbia Birth Control Pills Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.6. Rest of South America
8.6.6.1. Rest of South America Birth Control Pills Revenue (Millions USD) and Growth Rate (2017-2027)
8.7. Middle East and Africa Birth Control Pills by Countries
8.7.1. Middle East and Africa Birth Control Pills Revenue and Growth Rate (2017-2027)
8.7.2. Middle East and Africa Birth Control Pills Revenue (Million USD) by Countries (2017-2027)
8.7.3. Saudi Arabia
8.7.3.1. Saudi Arabia Birth Control Pills Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.4. United Arab Emirates
8.7.4.1. United Arab Emirates Birth Control Pills Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.5. Egypt
8.7.5.1. Egypt Birth Control Pills Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.6. Nigeria
8.7.6.1. Nigeria Birth Control Pills Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.7. South Africa
8.7.7.1. South Africa Birth Control Pills Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.8. Turkey
8.7.8.1. Turkey Birth Control Pills Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.9. Rest of Middle East and Africa
8.7.9.1. Rest of Middle East and Africa Birth Control Pills Revenue (Millions USD) and Growth Rate (2017-2027)
9. Company Profiles
9.1. Bayer Healthcare
9.1.1. Business Overview
9.1.2. Service Portfolio
9.1.3. Strategic Developments
9.1.4. Financial Overview
9.2. Amgen Inc.c
9.2.1. Business Overview
9.2.2. Service Portfolio
9.2.3. Strategic Developments
9.2.4. Financial Overview
9.3. Baxter
9.3.1. Business Overview
9.3.2. Service Portfolio
9.3.3. Strategic Developments
9.3.4. Financial Overview
9.4. Gilead Sciences Inc.
9.4.1. Business Overview
9.4.2. Service Portfolio
9.4.3. Strategic Developments
9.4.4. Financial Overview
9.5. GlaxoSmithKline PLC
9.5.1. Business Overview
9.5.2. Service Portfolio
9.5.3. Strategic Developments
9.5.4. Financial Overview
9.6. Johnson & Johnson
9.6.1. Business Overview
9.6.2. Service Portfolio
9.6.3. Strategic Developments
9.6.4. Financial Overview
9.7. Merck & Co. Inc.
9.7.1. Business Overview
9.7.2. Service Portfolio
9.7.3. Strategic Developments
9.7.4. Financial Overview
9.8. Novartis AG
9.8.1. Business Overview
9.8.2. Service Portfolio
9.8.3. Strategic Developments
9.8.4. Financial Overview
9.9. Pfizer Inc.
9.9.1. Business Overview
9.9.2. Service Portfolio
9.9.3. Strategic Developments
9.9.4. Financial Overview
9.10. Sanofi
9.10.1. Business Overview
9.10.2. Service Portfolio
9.10.3. Strategic Developments
9.10.4. Financial Overview
10. Birth Control Pills Market Forecast (2017-2027)
10.1. Global Birth Control Pills Revenue (Millions USD) and Growth Rate (2017-2027)
10.2. Birth Control Pills Market Forecast by Regions (2017-2027)
10.2.1. North America Birth Control Pills Market Forecast (2017-2027)
10.2.1.1. United States Birth Control Pills Market Forecast (2017-2027)
10.2.1.2. Canada Birth Control Pills Market Forecast (2017-2027)
10.2.1.3. Mexico Birth Control Pills Market Forecast (2017-2027)
10.2.2. Europe Birth Control Pills Market Forecast (2017-2027)
10.2.2.1. Germany Birth Control Pills Market Forecast (2017-2027)
10.2.2.2. France Birth Control Pills Market Forecast (2017-2027)
10.2.2.3. UK Birth Control Pills Market Forecast (2017-2027)
10.2.2.4. Russia Birth Control Pills Market Forecast (2017-2027)
10.2.2.5. Italy Birth Control Pills Market Forecast (2017-2027)
10.2.2.6. Rest of Europe Birth Control Pills Market Forecast (2017-2027)
10.2.3. Asia-Pacific Birth Control Pills Market Forecast (2017-2027)
10.2.3.1. China Birth Control Pills Market Forecast (2017-2027)
10.2.3.2. Japan Birth Control Pills Market Forecast (2017-2027)
10.2.3.3. Korea Birth Control Pills Market Forecast (2017-2027)
10.2.3.4. India Birth Control Pills Market Forecast (2017-2027)
10.2.3.5. Southeast Asia Birth Control Pills Market Forecast (2017-2027)
10.2.3.6. Rest of Asia-Pacific Birth Control Pills Market Forecast (2017-2027)
10.2.4. South America Birth Control Pills Market Forecast (2017-2027)
10.2.4.1. Brazil Birth Control Pills Market Forecast (2017-2027)
10.2.4.2. Argentina Birth Control Pills Market Forecast (2017-2027)
10.2.4.3. Columbia Birth Control Pills Market Forecast (2017-2027)
10.2.4.4. Rest of South America Birth Control Pills Market Forecast (2017-2027)
10.2.5. Middle East and Africa Birth Control Pills Market Forecast (2017-2027)
10.2.5.1. Saudi Arabia Birth Control Pills Market Forecast (2017-2027)
10.2.5.2. United Arab Emirates Birth Control Pills Market Forecast (2017-2027)
10.2.5.3. Egypt Birth Control Pills Market Forecast (2017-2027)
10.2.5.4. Nigeria Birth Control Pills Market Forecast (2017-2027)
10.2.5.5. South Africa Birth Control Pills Market Forecast (2017-2027)
10.2.5.6. Turkey Birth Control Pills Market Forecast (2017-2027)
10.2.5.7. Rest of Middle East and Africa Birth Control Pills Market Forecast (2017-2027)
10.3. Birth Control Pills Market Forecast by Type (2017-2027)
10.3.1. Birth Control Pills Forecast by Type (2017-2027)
10.3.2. Birth Control Pills Market Share Forecast by Type (2017-2027)
10.4. Birth Control Pills Market Forecast by Hormones (2017-2027)
10.4.1. Birth Control Pills Forecast by Hormones (2017-2027)
10.4.2. Birth Control Pills Market Share Forecast by Hormones (2017-2027)
10.5. Birth Control Pills Market Forecast by End User (2017-2027)
10.5.1. Birth Control Pills Forecast by End User (2017-2027)
10.5.2. Birth Control Pills Market Share Forecast by End User (2017-2027)
List of Tables
List of Tables and Figures:
Figure United States Birth Control Pills Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Birth Control Pills Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Birth Control Pills Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Birth Control Pills Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Birth Control Pills Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Birth Control Pills Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Birth Control Pills Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Birth Control Pills Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Birth Control Pills Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Birth Control Pills Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Birth Control Pills Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Birth Control Pills Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Birth Control Pills Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Birth Control Pills Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Birth Control Pills Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Birth Control Pills Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Birth Control Pills Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Birth Control Pills Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Birth Control Pills Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Birth Control Pills Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Birth Control Pills Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Birth Control Pills Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Birth Control Pills Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Birth Control Pills Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Birth Control Pills Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Birth Control Pills Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Birth Control Pills Revenue and Revenue Share by Type (2017-2018)
Figure Global Oral Contraceptive Pills Revenue and Growth Rate (2017-2018)
Figure Global Injectable Birth Control Revenue and Growth Rate (2017-2018)
Figure Global Emergency Contraceptive Pills Revenue and Growth Rate (2017-2018)
Figure Global Vaginal Rings Revenue and Growth Rate (2017-2018)
Figure Global Transdermal Patches Revenue and Growth Rate (2017-2018)
Table Global Birth Control Pills Revenue and Revenue Share by Hormones (2017-2018)
Figure Global Progestin-only Contraceptive Revenue and Growth Rate (2017-2018)
Figure Global Combined Hormonal Contraceptive Revenue and Growth Rate (2017-2018)
Table Global Birth Control Pills Revenue and Revenue Share by End User (2017-2018)
Figure Global Hospitals Revenue and Growth Rate (2017-2018)
Figure Global Household Revenue and Growth Rate (2017-2018)
Figure Global Clinics Revenue and Growth Rate (2017-2018)
Table Global Birth Control Pills Revenue by Regions (2017-2018)
Figure North America Birth Control Pills Growth Rate (2017-2018)
Figure North America Birth Control Pills Revenue and Growth Rate (2017-2018)
Figure North America Birth Control Pills by Countries (2017-2018)
Figure North America Birth Control Pills Revenue (Million USD) by Countries (2017-2018)
Figure United States Birth Control Pills Growth Rate (2017-2018)
Figure United States Birth Control Pills Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Birth Control Pills Growth Rate (2017-2018)
Figure Canada Birth Control Pills Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Birth Control Pills Growth Rate (2017-2018)
Figure Mexico Birth Control Pills Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Birth Control Pills Growth Rate (2017-2018)
Figure Europe Birth Control Pills Revenue and Growth Rate (2017-2018)
Figure Europe Birth Control Pills by Countries (2017-2018)
Figure Europe Birth Control Pills Revenue (Million USD) by Countries (2017-2018)
Figure Germany Birth Control Pills Growth Rate (2017-2018)
Figure Germany Birth Control Pills Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Birth Control Pills Growth Rate (2017-2018)
Figure France Birth Control Pills Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Birth Control Pills Growth Rate (2017-2018)
Figure UK Birth Control Pills Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Birth Control Pills Growth Rate (2017-2018)
Figure Russia Birth Control Pills Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Birth Control Pills Growth Rate (2017-2018)
Figure Italy Birth Control Pills Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Birth Control Pills Growth Rate (2017-2018)
Figure Rest of Europe Birth Control Pills Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Birth Control Pills Growth Rate (2017-2018)
Figure Asia-Pacific Birth Control Pills Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Birth Control Pills by Countries (2017-2018)
Figure Asia-Pacific Birth Control Pills Revenue (Million USD) by Countries (2017-2018)
Figure China Birth Control Pills Growth Rate (2017-2018)
Figure China Birth Control Pills Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Birth Control Pills Growth Rate (2017-2018)
Figure Japan Birth Control Pills Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Birth Control Pills Growth Rate (2017-2018)
Figure Korea Birth Control Pills Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Birth Control Pills Growth Rate (2017-2018)
Figure India Birth Control Pills Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Birth Control Pills Growth Rate (2017-2018)
Figure Southeast Asia Birth Control Pills Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Birth Control Pills Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Birth Control Pills Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Birth Control Pills Growth Rate (2017-2018)
Figure South America Birth Control Pills Revenue and Growth Rate (2017-2018)
Figure South America Birth Control Pills by Countries (2017-2018)
Figure South America Birth Control Pills Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Birth Control Pills Growth Rate (2017-2018)
Figure Brazil Birth Control Pills Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Birth Control Pills Growth Rate (2017-2018)
Figure Argentina Birth Control Pills Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Birth Control Pills Growth Rate (2017-2018)
Figure Columbia Birth Control Pills Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Birth Control Pills Growth Rate (2017-2018)
Figure Rest of South America Birth Control Pills Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Birth Control Pills Growth Rate (2017-2018)
Figure Middle East and Africa Birth Control Pills Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Birth Control Pills by Countries (2017-2018)
Figure Middle East and Africa Birth Control Pills Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Birth Control Pills Growth Rate (2017-2018)
Figure Saudi Arabia Birth Control Pills Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Birth Control Pills Growth Rate (2017-2018)
Figure United Arab Emirates Birth Control Pills Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Birth Control Pills Growth Rate (2017-2018)
Figure Egypt Birth Control Pills Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Birth Control Pills Growth Rate (2017-2018)
Figure Nigeria Birth Control Pills Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Birth Control Pills Growth Rate (2017-2018)
Figure South Africa Birth Control Pills Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Birth Control Pills Growth Rate (2017-2018)
Figure Turkey Birth Control Pills Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Birth Control Pills Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Birth Control Pills Revenue (Millions USD) and Growth Rate (2017-2018)
Table Bayer Healthcare Birth Control Pills Financial Overview
Table Amgen Inc.c Birth Control Pills Financial Overview
Table Baxter Birth Control Pills Financial Overview
Table Gilead Sciences Inc. Birth Control Pills Financial Overview
Table GlaxoSmithKline PLC Birth Control Pills Financial Overview
Table Johnson & Johnson Birth Control Pills Financial Overview
Table Merck & Co. Inc. Birth Control Pills Financial Overview
Table Novartis AG Birth Control Pills Financial Overview
Table Pfizer Inc. Birth Control Pills Financial Overview
Table Sanofi Birth Control Pills Financial Overview
Figure Global Birth Control Pills Revenue (Millions USD) and Growth Rate (2018-2025)
Table Birth Control Pills Market Forecast by Regions (2018-2025)
Figure North America Birth Control Pills Market Forecast (2018-2025)
Figure United States Birth Control Pills Market Forecast (2018-2025)
Figure Canada Birth Control Pills Market Forecast (2018-2025)
Figure Mexico Birth Control Pills Market Forecast (2018-2025)
Figure Europe Birth Control Pills Market Forecast (2018-2025)
Figure Germany Birth Control Pills Market Forecast (2018-2025)
Figure France Birth Control Pills Market Forecast (2018-2025)
Figure UK Birth Control Pills Market Forecast (2018-2025)
Figure Russia Birth Control Pills Market Forecast (2018-2025)
Figure Italy Birth Control Pills Market Forecast (2018-2025)
Figure Rest of Europe Birth Control Pills Market Forecast (2018-2025)
Figure Asia-Pacific Birth Control Pills Market Forecast (2018-2025)
Figure China Birth Control Pills Market Forecast (2018-2025)
Figure Japan Birth Control Pills Market Forecast (2018-2025)
Figure Korea Birth Control Pills Market Forecast (2018-2025)
Figure India Birth Control Pills Market Forecast (2018-2025)
Figure Southeast Asia Birth Control Pills Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Birth Control Pills Market Forecast (2018-2025)
Figure South America Birth Control Pills Market Forecast (2018-2025)
Figure Brazil Birth Control Pills Market Forecast (2018-2025)
Figure Argentina Birth Control Pills Market Forecast (2018-2025)
Figure Columbia Birth Control Pills Market Forecast (2018-2025)
Figure Rest of South America Birth Control Pills Market Forecast (2018-2025)
Figure Middle East and Africa Birth Control Pills Market Forecast (2018-2025)
Figure Saudi Arabia Birth Control Pills Market Forecast (2018-2025)
Figure United Arab Emirates Birth Control Pills Market Forecast (2018-2025)
Figure Egypt Birth Control Pills Market Forecast (2018-2025)
Figure Nigeria Birth Control Pills Market Forecast (2018-2025)
Figure South Africa Birth Control Pills Market Forecast (2018-2025)
Figure Turkey Birth Control Pills Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Birth Control Pills Market Forecast (2018-2025)
Figure Global Birth Control Pills Forecast by Type (2018-2025)
Figure Global Birth Control Pills Market Share Forecast by Type (2018-2025)
Figure Global Birth Control Pills Forecast by Type (2018-2025)
Figure Global Birth Control Pills Forecast by Hormones (2018-2025)
Figure Global Birth Control Pills Market Share Forecast by Hormones (2018-2025)
Figure Global Birth Control Pills Forecast by Hormones (2018-2025)
Figure Global Birth Control Pills Forecast by End User (2018-2025)
Figure Global Birth Control Pills Market Share Forecast by End User (2018-2025)
Figure Global Birth Control Pills Forecast by End User (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|